Jun
2026
Shanghai New International Expo Center
Visit us
stand W9B60, Biotech
Zone

HyQure BioTech

About Us

HyQure Biotech is a trusted partner for innovative drug developers worldwide, providing end-to-end Biosafety and lot release testing solutions throughout the entire drug lifecycle--from preclinical research to commercial production. Our services include virus clearance validation, cell bank identification, commercial batch release, replication-competent virus (RCL, rcAAV, RCR, etc.) testing, testing services for HCD and HCP kits.

  • Country/Region:
    China
  • On CPHI since:
    2025
  • Certificates:
    4
  • Employees:
    100 - 249
Company types
Contract Research Organisation (CRO)
Primary activities
Contract Research Organisation
Contact info
  • Building 18, Lane 2777 East Jinxiu Road,, 200120, shanghai, China
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand W9B60, Biotech

Products Featured at CPHI & PMEC China 2026

  • one-stop Biosafety Service

    Product one-stop Biosafety Service

    HyQure Biotech是一家领先的一站式生物安全服务平台,专注于大分子和CGT(细胞与基因治疗)药物。我们的核心能力包括: 1.病毒清除验证 2.细胞库特征分析 3.商业批次发布测试 4.复制适应性病毒检测(RCL、rcAAV、RCR、RCA) 5.宿主细胞蛋白/残留DNA检测套件

HYQURE Biotech Resources (1)

  • Video About HYQURE

    HYQURE focuses on biosafety testing specializing in Biologics and cell/gene therapy. As a trusted, global-compliant partner to 300+ recognized biotechs/biopharmas, we have had more than 110 successfully approved IND or BLA cases and more than 50 of them have been approved by FDA, EMA, TGA etc. The capability of methodologies and quality systems we’ve built have been recognized by global regulatory authorities.